SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-118119
Filing Date
2020-04-24
Accepted
2020-04-24 07:30:56
Documents
6
Period of Report
2020-06-11
Effectiveness Date
2020-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A d898012ddef14a.htm DEF 14A 338465
2 GRAPHIC g898012g11x12.jpg GRAPHIC 1806
3 GRAPHIC g898012g26b94.jpg GRAPHIC 11070
4 GRAPHIC g898012g31e55.jpg GRAPHIC 1800
5 GRAPHIC g898012g50c16.jpg GRAPHIC 51277
6 GRAPHIC g898012g56q65.jpg GRAPHIC 31419
  Complete submission text file 0001193125-20-118119.txt   468908
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

IRS No.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38529 | Film No.: 20812481
SIC: 2834 Pharmaceutical Preparations